Publication:
Serum prolidase, malondialdehyde and catalase levels for the evaluation of oxidative stress in patients with peripheral vertigo.

Loading...
Thumbnail Image

relationships.isOrgUnitOf

Program

relationships.isAuthorOf

Author

Ozbay, Isa

Topuz, Muhammet Fatih

Oghan, Fatih

Kocak, Havva

Kucur, Cuneyt

Advisor

Language

Type

Publisher

Journal Title

Journal ISSN

Volume Title

Abstract

We aimed to evaluate oxidative stress in patients with peripheral vertigo by measuring serum prolidase, malondialdehyde (MDA) and catalase levels.
A total of 30 patients (age: 60 <) with peripheral vertigo and 30 healthy subjects were recruited. Blood samples were collected from both groups and serum prolidase levels were measured using enzyme-linked immunosorbent assay (ELISA). MDA and catalase levels were measured by the spectrophotometric method.
The most common cause of vertigo was BPPV (53.3%), followed by Ménière's disease (16.6%), vestibular neuritis (13.3%), lateral semicircular canal fistula (3.3%), and idiopathic vertigo (13.3%). Mean serum prolidase activity and MDA levels were significantly higher in the vertigo patients than in the control subjects (P < 0.05); however, there was no statistically significant difference in mean serum catalase levels between the groups (P > 0.05).
We concluded that serum prolidase and MDA levels may be used as markers of oxidative stress in patients with peripheral vertigo.

Description

Source

Keywords

Citation

Endorsement

Review

Supplemented By

Referenced By

2

Views

73

Downloads

View PlumX Details


Sustainable Development Goals